newsfilter
← Latest News
Business Wire·

Outcome of Innate Pharma's 2026 Annual General Meeting

Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") announced the voting results of its shareholders at the Annual General Meeting ("AGM"), which took place on May 21, 2026, in